(Q34248044)

English

Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25309466%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

Europe PubMed Central

Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25309466%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

0 references

cardiovascular disease

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Ole A. Andreassen

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25309466%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Petter Andreas Ringen

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25309466%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

John A Engh

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25309466%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Astrid B Birkenaes

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25309466%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Ingrid Dieset

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25309466%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

26 September 2014

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25309466%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Frontiers in Psychiatry

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25309466%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25309466%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

137

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25309466%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Pharmacological mechanisms underlying the association of antipsychotics with metabolic disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

A comprehensive review on metabolic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Comparison of the long-term effects of high-fat v. low-fat diet consumption on cardiometabolic risk factors in subjects with abnormal glucose metabolism: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Ontogeny of taste preferences: basic biology and implications for health.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Comorbidity of severe psychotic disorders with measures of substance use

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Excess early mortality in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Modelling the incidence and mortality of psychotic disorders: data from the second Australian national survey of psychosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Long-term drug treatment for obesity: a systematic and clinical review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Postmortem analysis of cardiovascular deaths in schizophrenia: a 10-year review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Mediterranean diet and metabolic syndrome: an updated systematic review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Does smoking reduction in midlife reduce mortality risk? Results of 2 long-term prospective cohort studies of men and women in Scotland

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Mortality in persons with mental disorders is substantially overestimated using inpatient psychiatric diagnoses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Smoking cessation in people with schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

An exploratory study examining lipid-lowering medications in reducing fasting serum lipids in schizophrenia patients treated with atypical antipsychotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

The impact of smoking cessation on schizophrenia and major depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Randomized double-blind placebo-controlled study of leptin administration after gastric bypass

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Phentermine/topiramate for the treatment of obesity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Interventions for smoking cessation and reduction in individuals with schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Detection of metabolic syndrome in schizophrenia and implications for antipsychotic therapy : is there a role for folate?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

The dietary pattern of patients with schizophrenia: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Schizophrenia: metabolic aspects of aetiology, diagnosis and future treatment strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Psychopharmacologic treatment of obesity and eating disorders in children and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

The role of dietary fatty acids in the pathology of metabolic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Alternative dietary indices both strongly predict risk of chronic disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Life expectancy and cardiovascular mortality in persons with schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

A systematic review of correlates of physical activity in patients with schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Schizophrenia: medical illness, mortality, and aging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Effects of smoking cannabis on lung function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Sudden deaths in psychiatric patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Motivational interviewing: a useful approach to improving cardiovascular health?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Public health importance of triggers of myocardial infarction: a comparative risk assessment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Effects of high aerobic intensity training in patients with schizophrenia: a controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Incentives and barriers to lifestyle interventions for people with severe mental illness: a narrative synthesis of quantitative, qualitative and mixed methods studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Effect of a motivational intervention on exercise behavior in persons with schizophrenia spectrum disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Reward, dopamine and the control of food intake: implications for obesity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Increased Framingham 10-year risk of coronary heart disease in middle-aged and older patients with psychotic symptoms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Review: Are there modifiable risk factors which will reduce the excess mortality in schizophrenia?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Mortality in schizophrenia: a measurable clinical endpoint

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Exploring the construct validity of the transtheoretical model to structure physical activity interventions for individuals with serious mental illness

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

The Scandinavian Solutions for Wellness study - a two-arm observational study on the effectiveness of lifestyle intervention on subjective well-being and weight among persons with psychiatric disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

What can we do to reduce the burden of avoidable deaths in those with serious mental illness?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Exercise therapy for schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

An update on the role of markers of inflammation in atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Smoking and mental illness: results from population surveys in Australia and the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Influence of antipsychotics on mortality in schizophrenia: systematic review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Ten things that motivational interviewing is not.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Delusions are associated with poor cognitive insight in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Atypical antipsychotic drugs and the risk of sudden cardiac death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Access to medical care among persons with psychotic and major affective disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Reward processing in schizophrenia: a deficit in the representation of value

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Schizophrenia: a concise overview of incidence, prevalence, and mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Major physical and psychological harms of methamphetamine use

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Hypoalgesia in schizophrenia is independent of antipsychotic drugs: a systematic quantitative review of experimental studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Cigarette smoking among adults--United States, 2006

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Physical illness and schizophrenia: a review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

The social causes of psychosis in North American psychiatry: a review of a disappearing literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Behavioral therapy for weight loss in patients with schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Health habits of patients with schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Inequalities in the primary care of patients with coronary heart disease and serious mental health problems: a cross-sectional study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Interventions to reduce weight gain in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Physical health care of patients with schizophrenia in primary care: a comparative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Nutrition recommendations for the treatment and prevention of type 2 diabetes and the metabolic syndrome: an evidenced-based review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Schizophrenia and increased risks of cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Size of burden of schizophrenia and psychotic disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Clozapine, risperidone, olanzapine, and conventional antipsychotic drug effects on glucose, lipids, and leptin in schizophrenic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Motivational interviewing in health settings: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Obesity wars: molecular progress confronts an expanding epidemic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Optimal diets for prevention of coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Antipsychotic-induced weight gain: a review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Motivational interviewing in health care settings. Opportunities and limitations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Mortality and causes of death in schizophrenia in Stockholm county, Sweden

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Addiction and schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Excess mortality of schizophrenia. A meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

What are the functional consequences of neurocognitive deficits in schizophrenia?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Pain insensitivity in schizophrenic patients. A surgical dilemma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

Pain insensitivity in schizophrenia. Case report and review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 July 2018

A Systematic Review of Mortality in Schizophrenia

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Increasing mortality in schizophrenia: are women at particular risk? A follow-up of 1111 patients admitted during 1980-2006 in Northern Norway.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Cancer mortality in patients with schizophrenia: an 11-year prospective cohort study.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Rsearch Database

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Comorbidities and mortality in bipolar disorder: a Swedish national cohort study

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Obesity among those with mental disorders: a National Institute of Mental Health meeting report.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Mortality and its determinants in people with psychotic disorder

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Patterns of tobacco-related mortality among individuals diagnosed with schizophrenia, bipolar disorder, or depression.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

The level of illicit drug use is related to symptoms and premorbid functioning in severe mental illness

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Mortality rates and predictors of mortality among late-middle-aged and older substance abuse patients

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional study

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

From dopamine to salience to psychosis--linking biology, pharmacology and phenomenology of psychosis.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Validation of a physical activity assessment tool for individuals with schizophrenia.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Effects of exercise on mental and physical health parameters of persons with schizophrenia.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Description of physical activity in outpatients with schizophrenia spectrum disorders.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Lack of physical activity during leisure time contributes to an impaired health related quality of life in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Marital and labor market status in the long run in schizophrenia.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

A clinical study of the association of antipsychotics with hyperlipidemia.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: findings of a randomized clinical trial in a drug-naïve population

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Changes in weight in patients receiving a tranquilizing drug

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

From the Cover: Antipsychotic drug-induced weight gain mediated by histamine H1 receptor-linked activation of hypothalamic AMP-kinase

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Hormonal markers of metabolic dysregulation in patients with severe mental disorders after olanzapine treatment under real-life conditions

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Increased expression of lipid biosynthesis genes in peripheral blood cells of olanzapine-treated patients

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Comparative mortality risk in adult patients with schizophrenia, depression, bipolar disorder, anxiety disorders, and attention-deficit/hyperactivity disorder participating in psychopharmacology clinical trials

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Antipsychotics and mortality in first-onset schizophrenia: prospective Finnish register study with 5-year follow-up

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Antipsychotics and the risk of sudden cardiac death

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Thioridazine and sudden unexplained death in psychiatric in-patients.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Studies based on the Danish Adoption Register: schizophrenia, BMI, smoking, and mortality in perspective.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Identifying common genetic variants in blood pressure due to polygenic pleiotropy with associated phenotypes

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Adipocytes express a functional system for serotonin synthesis, reuptake and receptor activation.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

The metabolic syndrome in schizophrenia: is inflammation a contributing cause?

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Recognition of co-occurring medical conditions among patients with serious mental illness.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Use of general medical services among Medicaid patients with severe and persistent mental illness.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Occurrence of Painless Myocardial Infarction in Psychotic Patients

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

The role of the insula in schizophrenia

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Receipt of preventive medical services at psychiatric visits by patients with severe mental illness.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Excess mortality among long-stay psychiatric patients in Northern Finland

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Smoking reduction at midlife and lifetime mortality risk in men: a prospective cohort study

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Interventions for smoking cessation and reduction in individuals with schizophrenia

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Influence of moderate, daily physical activity on body composition and blood lipid profile in Swedish adults

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

A small group aerobic exercise programme that reduces body weight is feasible in adults with severe chronic schizophrenia: a pilot study

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

A behavioral weight-loss intervention for persons with serious mental illness in psychiatric rehabilitation centers.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Pedometer walking plus motivational interviewing program for Thai schizophrenic patients with obesity or overweight: a 12-week, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Exercise therapy improves mental and physical health in schizophrenia: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Multi-modal weight control intervention for people with persistent mental disorders

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

The effect of reboxetine co-administration with olanzapine on metabolic and endocrine profile in schizophrenia patients.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Surgical treatment of morbid obesity in schizophrenic patients.

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Motivational interviewing: an evidence-based approach to counseling helps patients follow treatment recommendations

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Schizophrenia guidelines across the world: a selective review and comparison

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiolog

1 reference

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

Second-generation antipsychotic use in schizophrenia and associated weight gain: a critical review and meta-analysis of behavioral and pharmacologic treatments.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 October 2018

Psychiatric illness and obesity: recognizing the "obesogenic" nature of an inpatient psychiatric setting.

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 October 2018

https://api.crossref.org/works/10.3389%2FFPSYT.2014.00137

21 January 2018

A naturalistic multicenter trial of a 12-week weight management program for overweight and obese patients with schizophrenia or schizoaffective disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 October 2018

Bridging the gap between mental and physical health: a multidisciplinary approach.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 October 2018

Metabolic syndrome and depression: a cross-sectional analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 October 2018

A 4-fold risk of metabolic syndrome in patients with schizophrenia: the Northern Finland 1966 Birth Cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 October 2018

Mortality in Norwegian mental hospitals 1926-1941.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 October 2018

Metabolic syndrome in patients with schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 October 2018

Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 October 2018

The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4175996

28 October 2018

Adults with mood disorders have an increased risk profile for cardiovascular disease within the first 2 years of treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/25309466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Base rates of physical activity in Australians with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25309466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: an animal model

1 reference

https://pubmed.ncbi.nlm.nih.gov/25309466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999-2011

1 reference

https://pubmed.ncbi.nlm.nih.gov/25309466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25309466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic findings from the CATIE trial and their relation to tolerability

1 reference

https://pubmed.ncbi.nlm.nih.gov/25309466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25309466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pain insensitivity in the relatives of schizophrenia patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/25309466

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3389/FPSYT.2014.00137

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25309466%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25309466%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25309466%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34248044&oldid=1499759572"